Rallybio Corporation

Rallybio Corporationverified

RLYB

Price:

$15.92

Market Cap:

$84.35M

Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Its most advanced therapeutic candidate, RLYB212, is a monoclonal anti-HPA-1a antibody currently undergoing Phase II clinical trials. This candidate, along with RLYB211, is aimed at preventing fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company's pipeline also includes RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for addressing ophthalmic conditions driven by complement system activity. Furthermore, RLYB116, an inhibitor designed to targe...[Read more]

Industry

Biotechnology

IPO Date

2021-07-29

Stock Exchange

NASDAQ

Ticker

RLYB

The Enterprise Value as of June 2026 (TTM) for Rallybio Corporation (RLYB) is 43.20M

According to Rallybio Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 43.20M. This represents a change of 4.24% compared to the average of 996.22K of the last 4 quarters.

Rallybio Corporation (RLYB) Historical Enterprise Value (quarterly & annually)

How has RLYB Enterprise Value performed in the past?

The mean historical Enterprise Value of Rallybio Corporation over the last ten years is 121.68M. The current 43.20M Enterprise Value has changed 3.45% with respect to the historical average. Over the past ten years (40 quarters), RLYB's Enterprise Value was at its highest in in the September 2022 quarter at 394.24M. The Enterprise Value was at its lowest in in the September 2025 quarter at -9451027.24.

Quarterly (TTM)
Annual

Average

121.68M

Median

131.19M

Minimum

-292758.70

Maximum

294.19M

Rallybio Corporation (RLYB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rallybio Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 16.37%

Maximum Annual Enterprise Value = 294.19M

Minimum Annual Increase = -101.04%

Minimum Annual Enterprise Value = -292758.70

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-292758.70-101.04%
202428.05M-61.34%
202372.57M-52.47%
2022152.66M16.37%
2021131.19M-24.35%
2020173.42M-41.05%

Rallybio Corporation (RLYB) Average Enterprise Value

How has RLYB Enterprise Value performed in the past?

The current Enterprise Value of Rallybio Corporation (RLYB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

33.44M

5-year avg

76.84M

10-year avg

121.68M

Rallybio Corporation (RLYB) Enterprise Value vs. Peers

How is RLYB’s Enterprise Value compared to its peers?

Rallybio Corporation’s Enterprise Value is greater than Intensity Therapeutics, Inc. (-3315836.00), greater than Sonnet BioTherapeutics Holdings, Inc. (3.36M), greater than Iterum Therapeutics plc (24.60M), greater than TAO Synergies Inc. (8.25M), greater than iBio, Inc. (-18621791.00), greater than Klotho Neurosciences, Inc. (13.75M), greater than Cadrenal Therapeutics, Inc. Common Stock (8.30M), greater than Exicure, Inc. (15.14M), less than Boundless Bio, Inc. (62.48M), less than Q32 Bio Inc. (121.73M),

Build a custom stock screener for Rallybio Corporation (RLYB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rallybio Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rallybio Corporation (RLYB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rallybio Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Rallybio Corporation's Enterprise Value?

What is the highest Enterprise Value for Rallybio Corporation (RLYB)?

What is the 3-year average Enterprise Value for Rallybio Corporation (RLYB)?

What is the 5-year average Enterprise Value for Rallybio Corporation (RLYB)?

How does the current Enterprise Value for Rallybio Corporation (RLYB) compare to its historical average?